{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T13:39:48Z","timestamp":1648906788261},"reference-count":27,"publisher":"Georg Thieme Verlag KG","issue":"08","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dtsch Med Wochenschr"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1055\/a-1267-5219","type":"journal-article","created":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T00:03:58Z","timestamp":1618445038000},"page":"518-524","source":"Crossref","is-referenced-by-count":0,"title":["Volumenmanagement bei chronischen Nierenerkrankungen"],"prefix":"10.1055","volume":"146","author":[{"given":"Ralph","family":"Kettritz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan Henrik","family":"Schirmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunnar Henrik","family":"Heine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2021,4,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nm.1960","article-title":"Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism","volume":"15","author":"A MacHnik","year":"2009","journal-title":"Nat Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/ki.2013.367","article-title":"Spooky sodium balance","volume":"85","author":"J Titze","year":"2014","journal-title":"Kidney Int"},{"key":"ref3","first-page":"308","article-title":"Acute renal success. The unexpected logic of oliguria in acute renal failure","volume":"61","author":"K Thurau","year":"1976","journal-title":"Am J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/0002-9343(82)90523-X","article-title":"Disorders of body fluids, sodium and potassium in chronic renal failure","volume":"72","author":"W E Much","year":"1982","journal-title":"Am J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1056\/NEJM198710223171702","article-title":"Salt-Sensitive Essential Hypertension in Men","volume":"317","author":"T W Kurtz","year":"1987","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/jamainternmed.2018.4204","article-title":"Effect of Increased Daily Water Intake in Premenopausal Women with Recurrent Urinary Tract Infections: A Randomized Clinical Trial","volume":"178","author":"T M Hooton","year":"2018","journal-title":"JAMA Intern Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i52","article-title":"Medical management of renal stones","volume":"352","author":"M SC Morgan","year":"2016","journal-title":"BMJ"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e008634","DOI":"10.1136\/bmjopen-2015-008634","article-title":"Effect of increased water intake on plasma copeptin in patients with chronic kidney disease: results from a pilot randomised controlled trial","volume":"5","author":"J M Sontrop","year":"2015","journal-title":"BMJ Open"},{"issue":"01","key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-018-0047-y","article-title":"Polycystic kidney disease","volume":"4","author":"C Bergmann","year":"2018","journal-title":"Nat Rev Dis Prim"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease","volume":"367","author":"V E Torres","year":"2012","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1056\/NEJMoa1710030","article-title":"Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease","volume":"377","author":"V E Torres","year":"2017","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1053\/j.ajkd.2016.07.023","article-title":"Low-Osmolar Diet and Adjusted Water Intake for Vasopressin Reduction in Autosomal Dominant Polycystic Kidney Disease: A Pilot Randomized Controlled Trial","volume":"68","author":"O W Amro","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/qjmed\/hcz278","article-title":"High water vs. ad libitum water intake for autosomal dominant polycystic kidney disease: A randomized controlled feasibility trial","volume":"113","author":"R El-Damanawi","year":"2020","journal-title":"QJM"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d4366","article-title":"Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: Randomised controlled trial","volume":"343","author":"M CJ Slagman","year":"2011","journal-title":"BMJ"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1681\/ASN.2007060693","article-title":"Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan","volume":"19","author":"L Vogt","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S2213-8587(14)70030-0","article-title":"Effects of sodium restriction and hydrochlorothiazide on RAAS blockade efficacy in diabetic nephropathy: A randomised clinical trial","volume":"2","author":"A J Kwakernaak","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1681\/ASN.2013030285","article-title":"A randomized trial of dietary sodium restriction in CKD","volume":"24","author":"E J McMahon","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/ki.2014.124","article-title":"Prescriptions for dietary sodium in patients with chronic kidney disease: How will this shake out?","volume":"86","author":"J P Middleton","year":"2014","journal-title":"Kidney Int"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1093\/eurheartj\/ehaa586","article-title":"Salt and cardiovascular disease: insufficient evidence to recommend low sodium intake","volume":"41","author":"M O\u2019Donnell","year":"2020","journal-title":"Eur Heart J"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1055\/a-0661-4426","article-title":"Diuretic Therapy","volume":"144","author":"S B\u00fcttner","year":"2019","journal-title":"Dtsch Med Wochenschr"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJM199808063390607","article-title":"Diuretic Therapy","volume":"339","author":"D C Brater","year":"1998","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/ejhf.1369","article-title":"The use of diuretics in heart failure with congestion \u2014 a position statement from the Heart Failure Association of the European Society of Cardiology","volume":"21","author":"W Mullens","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l359","article-title":"How to prescribe loop diuretics in oedema","volume":"364","author":"S D Anisman","year":"2019","journal-title":"BMJ"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1161\/CIRCULATIONAHA.120.048739","article-title":"Renal and Cardiovascular Effects of SGLT2 Inhibition in Combination with Loop Diuretics in Patients with Type 2 Diabetes and Chronic Heart Failure: The\u00a0RECEDE-CHF Trial","volume":"142","author":"N A Mordi","year":"2020","journal-title":"Circulation"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/CIRCULATIONAHA.117.028268","article-title":"Empagliflozin and clinical outcomes in patients with type 2 diabetes mellitus, established cardiovascular disease, and chronic kidney disease","volume":"137","author":"C Wanner","year":"2018","journal-title":"Circulation"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/ejhf.1917","article-title":"Diuretic and renal effects of spironolactone and heart failure hospitalizations: a TOPCAT Americas analysis","volume":"22","author":"A P Kalogeropoulos","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2025845","article-title":"Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes","volume":"383","author":"G L Bakris","year":"2020","journal-title":"N Engl J Med"}],"container-title":["DMW - Deutsche Medizinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1267-5219.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T00:05:12Z","timestamp":1618445112000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1267-5219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":27,"journal-issue":{"issue":"08","published-online":{"date-parts":[[2021,4,12]]},"published-print":{"date-parts":[[2021,4]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1267-5219","relation":{},"ISSN":["0012-0472","1439-4413"],"issn-type":[{"value":"0012-0472","type":"print"},{"value":"1439-4413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}